According to Accelerate Diagnostics's latest financial reports and stock price the company's current Operating Margin is -503.92%. At the end of 2023 the company had an Operating Margin of -503.92%.
Year | Operating Margin | Change |
---|---|---|
2023 | -503.92% | 2.7% |
2022 | -490.67% | -25.56% |
2021 | -659.12% | -5.9% |
2020 | -700.43% | -22.86% |
2019 | -907.99% | -41.57% |
2018 | -1,554.06% | 2.17% |
2017 | -1,521.07% | -94.34% |
2016 | -26,872.76% | -13.18% |
2015 | -30,951.02% | 22.07% |
2014 | -25,354.92% | -20.36% |
2013 | -31,837.50% | 1314.73% |
2012 | -2,250.42% | 6561.45% |
2011 | -33.78% | -224% |
2010 | 27.24% | -150.94% |
2009 | -53.48% | -84.87% |
2008 | -353.37% | -66.37% |
2007 | -1,050.75% | -26.25% |
2006 | -1,424.83% | 242.18% |
2005 | -416.40% | -70.93% |
2004 | -1,432.23% | -57.44% |
2003 | -3,365.17% | 2961.86% |
2002 | -109.91% | -49.57% |
2001 | -217.95% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.